Abiopharma

News list

MacLennan David 🟢 acquired 172 shares of ECOLAB INC. (ECL) at $263.68 Transaction Date: Dec 31, 2025 | Filing ID: 000002

Full text

News bot Jan. 5, 2026, 11:21 p.m.
🔍 MacLennan David (Executive)

Company: ECOLAB INC. (ECL)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 2
- Total shares acquired: 172
- Total shares held: 4,209
Detailed Transactions and Holdings:
- Acquired 128 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,180.20 | transaction_form_type: 4 | Footnotes: F1
- Acquired 44 shares of Common Stock at $263.675 per share (Direct)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,224.05 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: H | nature_of_ownership: By Kathleen F. MacLennan Revocable Trust u/a dated 11/07/2002 | shares_owned_after: 3,500.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-31 | Code: H | nature_of_ownership: By sibling's trusts | shares_owned_after: 709.00
Footnotes:
- F1: Includes 17.12 shares acquired pursuant to a dividend reinvestment feature of the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan.